Wouter is renowned for the quality and appropriateness of his advice, as well as his industry knowledge, political sense and knowledge of the playing field.
Wouter is a partner in, and head of, the IP department in The Hague.
He focuses on patent litigation, which also helps him to keep in touch with innovative technology. He handles a wide range of patent disputes, varying from mechanical issues through software and business method patents to biotech disputes, for both national and international clients.
In addition, Wouter is also involved in numerous trademark and copyright litigation matters, including cases before the Dutch Supreme Court and the European courts.
In recent years, database protection and trade secrets have become a more important part of Wouter’s practice, and he has handled litigation on these issues and participated in various expert meetings on the new European trade secret regime.
Wouter is the secretary of the Dutch group of AIPPI. He is also an expert on issues regarding the Unitary Patent and the Unified Patent Court, the new patent system that is expected to go live early 2015. He is working on this within Bird & Bird as well as AIPPI and EPLAW.
IAM Patent 1000 2012 comments: “Wouter Pors is an extremely experienced litigator who acts for major pharmaceutical, biotechnology and electronics businesses on disputes involving everything from mechanical issues to software.” Chambers Global 2012 says: “Wouter Pors leads the IP group, and has a broad practice covering patent, copyright and trademark litigation. A client remarks: ‘He is very well informed; I’ve had a very positive experience with him’.”
This biography is an extract from Who's Who Legal: Life Sciences which can be purchased from our Shop.
Wouter Pors also features in the following practice areas:
It is not possible to buy entry into any Who's Who Legal publication
Nominees have been selected based upon comprehensive, independent survey work with both general counsel and private practice lawyers worldwide. Only specialists who have met independent international research criteria are listed.